These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6467499)

  • 1. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T; D'Incalci M
    Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
    Sava G; Giraldi T; Perissin L; Zorzet S; Mallardi F; Grill V
    Tumori; 1984 Dec; 70(6):477-83. PubMed ID: 6531789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells.
    Tamaro M; Dolzani L; Monti-Bragadin C; Sava G
    Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G; Giraldi T; Zupi G; Sacchi A
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
    Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
    Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt in M 5076/73A ovarian reticular cell sarcoma of the mouse.
    Colombo T; Garattini S; Lassiani L; D'Incalci M
    Cancer Treat Rep; 1982 Nov; 66(11):1945-8. PubMed ID: 6754075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
    Beal DD; Skibba JL; Croft WA; Cohen SM; Bryan GT
    J Natl Cancer Inst; 1975 Apr; 54(4):951-7. PubMed ID: 1127724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
    Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
    Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Mitri E; Cherubino R
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
    Farquhar D; Benvenuto J
    J Med Chem; 1984 Dec; 27(12):1723-7. PubMed ID: 6502603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia.
    Sava G; Giraldi T; Bartoli-Klugmann F; Decorti G; Mallardi F
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):287-9. PubMed ID: 6538492
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G; Giraldi T; Nisi C; Bertoli G
    Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.
    Giraldi T; Sava G; Cherubino R; Bottiroli G; Mazzini G
    Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of DTIC (NSC-45388) in animals.
    Venditti JM
    Cancer Treat Rep; 1976 Feb; 60(2):135-40. PubMed ID: 1260771
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe myelosuppression from piperazinedione, (NSC No. 135758), cyclophosphamide plus dimethyl-triazeno-imidazole carboxamide (DTIC).
    Presant CA; Klahr C
    Cancer; 1977 Oct; 40(4):1386-9. PubMed ID: 907959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J; Catherall EJ; Cockburn A
    Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.